Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors

Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors

US Patent 7265260 · Granted Sep 4, 2007

Estimated economic value: $69,303,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Folate receptor targeted nanoparticle drug conjugates and uses thereof2024
Folate receptor targeted nanoparticle drug conjugates and uses thereof2023
Bispecific EGFR/IGFIR binding molecules2021
Method of treating cancer by administering multivalent fibronectin based scaffol2020
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules2019
Tricyclic compounds as anticancer agents2018
Multivalent fibronectin based scaffold domain proteins2018
Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules2017
Tricyclic compounds as anticancer agents2017
Combination therapy for the treatment of proliferative diseases2016
Tricyclic compounds as anticancer agents2016
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof2016